{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-159094","form_type":"8-K","ticker":"CTKB","cik":"0001831915","company_name":"Cytek Biosciences, Inc.","filed_at":"2024-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.545645+00:00","generated_at":"2026-06-01T05:07:10.069445+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cytek Biosciences 2024 annual meeting results: all proposals approved by shareholders","bullets":["Elected Wenbin Jiang and Michael Holder as Class III directors with 64.2M and 70.3M votes for, respectively.","Advisory vote on executive compensation approved: 63.5M for, 10.5M against, 78.9K abstentions.","Ratified Deloitte & Touche LLP as independent auditor for FY2024: 94.1M for, 2.3M against, 656.7K abstentions.","Approximately 74% of outstanding shares (97.1M of 131.3M) represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-159094","json":"https://secwatch.observer/filing/0001193125-24-159094.json","markdown":"https://secwatch.observer/filing/0001193125-24-159094.md","text":"https://secwatch.observer/filing/0001193125-24-159094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831915/000119312524159094/0001193125-24-159094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831915/000119312524159094/d841203d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:07:10.069445+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}